Volume 27, Issue 2 p. 920-932
ORIGINAL ARTICLE

Intermittent fasting for weight management and metabolic health: An updated comprehensive umbrella review of health outcomes

Zixin Hua MPharm

Zixin Hua MPharm

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Siyu Yang MPharm

Siyu Yang MPharm

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Jiqian Li MPharm

Jiqian Li MPharm

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Yiqi Sun MPharm

Yiqi Sun MPharm

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Yin Liao MPharm

Yin Liao MPharm

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Siyang Song PhD

Siyang Song PhD

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Sheng Cheng MPharm

Sheng Cheng MPharm

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Zhe Li MPharm

Zhe Li MPharm

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Ze Li PhD

Ze Li PhD

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Dandan Li MPharm

Dandan Li MPharm

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Heng Guo MPharm

Heng Guo MPharm

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Hongge Yang PhD

Hongge Yang PhD

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Yingming Zheng MPharm

Yingming Zheng MPharm

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
Xingang Li PhD

Corresponding Author

Xingang Li PhD

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Correspondence

Xingang Li, PhD, Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, No. 95 Yongan Road, Xicheng District, Beijing, 100050, China.

Email: lxg198320022003@163.com

Search for more papers by this author
First published: 01 December 2024

Abstract

Aims

To provide an updated comprehensive evaluation of the quality and evidence association of existing studies on health outcomes related to intermittent fasting (IF).

Materials and Methods

We conducted a systematic search of PubMed, Web of Science, Cochrane Library, and Embase databases, covering literature up to June 2024. Meta-analyses and systematic reviews that include adult populations and quantitatively analyse health outcomes related to IF interventional studies are included. For evidence with complete data, we reanalyzed health evidence effect sizes and 95% confidence intervals using random-effects models. Article quality and the certainty of the evidence were graded using A Measurement Tool to Assess Systematic Reviews (AMSTAR-2), Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, and a standardized credibility grading system.

Results

Twelve meta-analysis studies and 122 health outcome associations with IF were identified. High-quality evidence indicated significant associations between time-restricted eating (TRE) and weight loss, fat mass reduction, decreased fasting insulin and glycosylated haemoglobin levels in overweight or obese adults, as well as between the 5:2 diet and reduced low-density lipoprotein cholesterol levels. Moderate-to-low-quality evidence suggested associations between modified alternate-day fasting and improvements in body weight, lipid profile and blood pressure. Additionally, high-to-low-quality evidence showed that IF regimens effectively improved liver health in non-alcoholic fatty liver disease.

Conclusions

This umbrella review highlights IF, especially TRE, as a promising intervention for weight and metabolic health, particularly beneficial for overweight or obese adults. We also highlight the need for further extensive research to understand the long-term effects, individualized IF plans and potential adverse effects of IF in different populations.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest.

PEER REVIEW

The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.16092.

DATA AVAILABILITY STATEMENT

The datasets utilized and/or analysed throughout the present study are obtainable from the corresponding author upon reasonable request.